Bioharvest Sciences (BHST) EBITDA (2023 - 2025)

Bioharvest Sciences' EBITDA history runs 3 years deep, the most recent figure standing at -$1.1 million for Q4 2025.

• In Q4 2025, EBITDA rose 33.55% year-over-year to -$1.1 million; the TTM figure through Dec 2025 stood at -$5.6 million (up 20.23% YoY), while the FY2025 annual figure was -$5.6 million, up 20.23% from the prior year.
• EBITDA was -$1.1 million for Q4 2025 at Bioharvest Sciences, down from -$920000.0 in the prior quarter.
• In the past five years, EBITDA ranged from a high of $2.9 million in Q2 2023 to a low of -$17.4 million in Q4 2023.
• Historically, EBITDA has averaged -$2.3 million across 3 years, with a median of -$1.7 million in 2024.
• Biggest YoY gain for EBITDA was 90.3% in 2024; the steepest drop was 204.73% in 2024.
• A 3-year view of EBITDA shows it stood at -$17.4 million in 2023, then jumped by 90.3% to -$1.7 million in 2024, then soared by 33.55% to -$1.1 million in 2025.
• The last three EBITDA figures came in at -$1.1 million (Q4 2025), -$920000.0 (Q3 2025), and -$1.8 million (Q2 2025), per Business Quant data.